BioNTech

Use the mouse wheel or two fingers (on touchscreens) to zoom in and out of the map.

Map view:

Zoom: 100%

More settings

Connection length 100% Label size 100% Node size 100% Line width 100% Label width 100%

Export map as:

BioNTech topic overview

The analysis highlights History, Art, Technology and Companies as prominent areas in the source structure around BioNTech.

Related topics: 66
Source areas: 4
Connected nodes: 70
Extracted relationships: 219
Concept neighborhoods: 17
Bridge connections: 70

What this topic covers Research coverage

Source areas are shown by the number of related topics found in each part of the analysis. Use smaller areas too: they can reveal specialized angles and content gaps.

History · 39 topics

Company structure · 11 topics

Overview · 11 topics

Therapeutic areas · 5 topics

Smaller areas are not necessarily less important. They contain fewer connections in this analysis and can be useful for finding specialized angles or coverage gaps.

Key facts & relationships

High-confidence facts extracted from structured source data. Use them as anchors for further research.

Founded: 2008; 18 years ago (2008)
Founders: Uğur Şahin · Özlem Türeci · Christoph Huber
Industry: Biotechnology
Headquarters: Mainz, Germany
Area served: Worldwide
ISIN: US09075V1026

Explore all related topics Closing gaps

Browse the complete topic structure, not only the most central items. Less prominent entities and concepts can reveal missing angles, specialized context and useful research gaps. Each item opens a new analysis centered on that subject.

Therapeutic areas

Advanced semantic analysis

Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.

How BioNTech connects Entity context

The extracted context around BioNTech shows recurring relationship patterns in the source. For example, BioNTech → Africa, Asia, Australia, Austria, Berkeley Heights, Berlin, BioNTech's, Cambridge, China, England, Europe, Gaithersburg, Germany, GMP-certified, Halle, Idar-Oberstein, Istanbul, Kigali, London, Mainz Another extracted example is BioNTech → ADS, American Depository Shares, Bill, BNTX, BVCF Management, EIB, Europe, European Commission Investment Plan, European Investment Bank, Fidelity Management, In December, In July, In September, Invus, IPO, Jebsen Capital, Melinda Gates Foundation, Mirae Asset Financial Group, NASDAQ Global Select Market, October. Use these groups to spot repeated connection types before inspecting the individual relationships.

Top relations

related to Locations · 32

BioNTech → Africa, Asia, Australia, Austria, Berkeley Heights, Berlin, BioNTech's, Cambridge, China, England, Europe, Gaithersburg, Germany, GMP-certified, Halle, Idar-Oberstein, Istanbul, Kigali, London, Mainz

related to Series B financing and Nasdaq IPO (2019) · 28

BioNTech → ADS, American Depository Shares, Bill, BNTX, BVCF Management, EIB, Europe, European Commission Investment Plan, European Investment Bank, Fidelity Management, In December, In July, In September, Invus, IPO, Jebsen Capital, Melinda Gates Foundation, Mirae Asset Financial Group, NASDAQ Global Select Market, October

related to Foundation (2008–2014) · 24

BioNTech → All, Andreas, BioNTech's, Christoph Huber, EUFETS, Helmut Jeggle, Hungarian, In, JPT Peptide Technologies, Karikó, Katalin Karikó, Medicine, MIG Capital, Munich-based, Nobel Prize, Physiology, RNA, She, The, Their

related to COVID-19 (since 2020) · 22

BioNTech → April, China, Clinical, COVID-19, Due, Education, European Investment Bank, Fosun Pharma, German Federal Ministry, Germany, Hong Kong, In March, January, June, Macau, Pfizer, Project Lightspeed, Research, SARS-Cov-2, Singapore

related to Management Board · 19

BioNTech → Annemarie Hanekamp, Board, Chief Business Officer, Chief Commercial Officer, Chief Executive Officer, Chief Financial Officer, Chief Legal, Chief Medical Officer, Chief Operating Officer, Chief People Officer, In March, James Ryan, Kylie Jimenez, May, Ramón Zapata, Sierk Pötting, The, Türeci, Uğur

related to Pricing of the COVID vaccine · 16

BioNTech → Comirnaty, Comirnaty BioNTech, COVID, Critics, EU, German Medical Association, However, In August, It, June, Medicines Commission, NDR, Süddeutsche Zeitung, The, WDR, Wolf-Dieter Ludwig

related to Influence by the Chinese government · 13

BioNTech → China, Chinese, COVID-19, During, Fosun Pharma, However, May, Others, People's Republic, Republic, Taiwan, Taiwanese President Tsai Ing-wen, This

related to Expansion, Series A financing (2015–2018) · 10

BioNTech → Between, BioNTech's, Collaborations, In August, In January, Inc, Pfizer, Series, Under, US

related to Oncology · 10

BioNTech → BioNTech CEO Uğur, By, CAR-T, For, German, In November, May, These, To, ZDF

related to Oncology and international expansion (since 2021) · 8

BioNTech → AI-driven, Alongside, British AI, COVID-19, In, InstaDeep, SARS-CoV-2, The

Important terminology

Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.

Important terminology

company vaccine mrna-based covid-19 cancer mrna pfizer development research million 2020 vaccines manufacturing diseases germany 2026 us biontech's 2019 also

BioNTech relationships Subject–Predicate–Object triples

TTTA extracted 219 structured relationships around BioNTech. Examples in this analysis include BioNTech → Area served → Worldwide and BioNTech → Founded → 2008; 18 years ago (2008). The table shows each extracted connection, where it came from and its confidence.

Subject	Predicate	Object	Confidence	Src
BioNTech	Area served	Worldwide	1.00	infobox
BioNTech	Founded	2008; 18 years ago (2008)	1.00	infobox
BioNTech	Founders	Uğur Şahin	1.00	infobox
BioNTech	Founders	Özlem Türeci	1.00	infobox
BioNTech	Founders	Christoph Huber	1.00	infobox
BioNTech	Headquarters	Mainz, Germany	1.00	infobox
BioNTech	Industry	Biotechnology	1.00	infobox
BioNTech	ISIN	US09075V1026	1.00	infobox
BioNTech	Key people	Uğur Şahin (CEO)	1.00	infobox
BioNTech	Key people	Annemarie Hanekamp (CCO)	1.00	infobox
BioNTech	Key people	Kylie Jimenez (CPO)	1.00	infobox
BioNTech	Key people	Sierk Pötting (COO)	1.00	infobox
BioNTech	Key people	James Ryan (CLO, CBO)	1.00	infobox
BioNTech	Key people	Özlem Türeci (CMO)	1.00	infobox
BioNTech	Key people	Ramón Zapata (CFO)	1.00	infobox
BioNTech	Net income	€−1.14 billion (2025)	1.00	infobox
BioNTech	Number of employees	7,807 (2025)	1.00	infobox
BioNTech	Number of locations	26 (2026)	1.00	infobox
BioNTech	Operating income	€−1.40 billion (2025)	1.00	infobox
BioNTech	Products	Pfizer-BioNTech COVID-19 vaccine, Immunotherapy and vaccine candidates	1.00	infobox
BioNTech	Revenue	€2.87 billion (2025)	1.00	infobox
BioNTech	Services	Immunotherapy	1.00	infobox
BioNTech	Total assets	€21.99 billion (2025)	1.00	infobox
BioNTech	Total equity	€19.22 billion (2025)	1.00	infobox
BioNTech	Traded as	Nasdaq: BNTX	1.00	infobox
BioNTech	Type	Public company	1.00	infobox
BioNTech	Website	biontech.com	1.00	infobox

Related concept clusters Concept neighborhoods

The concept neighborhoods around BioNTech bring nearby vocabulary together. In this analysis, examples include Vaccine, Cancer and Million. Use the clusters to find adjacent concepts and terminology that may deserve separate research.

BioNTech
- Vaccine
- Cancer
- Million
- Covid-19
- Mrna-based
- Company
- Development
- Diseases
- Also
- Manufacturing
- Research
- Infectious
biontech
- Vaccine
- Cancer
- Million
- Covid-19
- Mrna-based
- Company
- Development
- Diseases
- Also
- Manufacturing
- Research
- Infectious
vaccines
- Mrna-based
- Infectious
- Development
- Clinical
- Developing
- Diseases
- Pfizer
- Company
- Covid-19
- Biotechnology
- Mainz
- Immunotherapies
fidelity management & research company
- Us
- Türeci
- Uğur
- Şahin
- Mrna-based
- Collaboration
- New
- Vaccines
- Mrna
- Research
- Development
- Vaccine
company structure
- Uğur
- Mrna-based
- Collaboration
- New
- Şahin
- Us
- Vaccines
- Research
- Vaccine
- Mainz
- Infectious
- Oncology
infectious diseases
- Diseases
- Infectious
- Mainz
- Immunotherapies
- Covid-19
- Vaccines
- Million
- Mrna-based
- Oncology
- Türeci
- Uğur
- Vaccine
covid-19 pandemic
- Vaccine
- Infectious
- Diseases
- Pfizer
- Oncology
- Mrna-based
- Production
- Germany
- Vaccines
- Manufacturing
- Mainz
- Türeci
uğur şahin
- Türeci
- Uğur
- Şahin
- Biotechnology
- Research
- Company
- Mainz
- Vaccine
- Infectious
- Oncology
- Diseases
- German

Connections between topic areas Semantic bridges

For BioNTech, one of the stronger structural bridges in this analysis connects BioNTech with History. Bridges highlight paths between different parts of the map and can reveal research angles that are easy to miss in a flat list.

Min side: 3

BioNTech — History · splits 31 ⟂ 40

BioNTech — Overview · splits 59 ⟂ 12

BioNTech — Company structure · splits 59 ⟂ 12

BioNTech — Therapeutic areas · splits 65 ⟂ 6

Map overview Semantic statistics

BioNTech

Nodes71

Edges70

Triples219

Avg. degree1.97

Density0.028169

Components1

Source & methodology

TTTA analyzes the structure around BioNTech to surface related topics, entities, relationships, concept neighborhoods and bridge connections. Use the map to explore areas such as History, Art, Technology & Companies, including less central topics that may reveal useful research gaps. Automatically extracted connections are research leads rather than rewritten encyclopedia content.

Source: Wikipedia — BioNTech · EN edition · Analysis: TopicsToTalkAbout